Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2010

01.06.2010 | Original Paper

Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues

verfasst von: Zhengjun Yi, Yurong Fu, Shushu Zhao, Xuguang Zhang, Chuanxiang Ma

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

MiRNAs are short single stranded RNAs that are associated with gene regulation at the transcriptional and translational level. Changes in their expression were found in a variety of human cancers. In the present study, we aimed to investigate expression profiles of miRNA (miRNA) in the clear cell subtype of kidney cancer and to develop further understanding of the molecular mechanisms involved in the pathogenesis of renal cell carcinoma.

Materials and methods

We analyzed the miRNA expression profiles in 30 pairs of renal cell carcinoma and adjacent nontumorous tissue (NT), using a mammalian miRNA microarray containing whole human mature and precursor miRNA sequences. Real-time quantitative PCR was performed to confirm the array results.

Results

The miRNA microarray chip analysis identified 86 miRNAs differentially expressed in renal cell carcinoma tissues and a total of 38 miRNAs exhibited higher expression in the renal cell carcinoma samples than that in the NT samples, while 48 miRNA demonstrated lower expression in the renal cell carcinoma samples than that in the NT samples.

Conclusion

Quantitative real-time PCR analysis confirmed microarray data. The report supports that many miRNA expressions were altered in renal carcinoma, whose expression profiling may provide a useful clue for the pathophysiology research. However, further longer-term researches are required to investigate the relationship between miRNA and renal carcinoma as well as their role in carcinogenesis.
Literatur
Zurück zum Zitat Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J (2009) miRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15(7):2281–2290CrossRefPubMed Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J (2009) miRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15(7):2281–2290CrossRefPubMed
Zurück zum Zitat Bartel DP (2004) MiRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297CrossRefPubMed Bartel DP (2004) MiRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297CrossRefPubMed
Zurück zum Zitat Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67(5):2345–2350CrossRefPubMed Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67(5):2345–2350CrossRefPubMed
Zurück zum Zitat Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16(12):939–946CrossRefPubMed Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16(12):939–946CrossRefPubMed
Zurück zum Zitat Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: miRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–D144CrossRefPubMed Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: miRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–D144CrossRefPubMed
Zurück zum Zitat Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for miRNA genomics. Nucleic Acids Res 36:D154–D158CrossRefPubMed Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for miRNA genomics. Nucleic Acids Res 36:D154–D158CrossRefPubMed
Zurück zum Zitat Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the miRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67(17):7972–7976CrossRefPubMed Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the miRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67(17):7972–7976CrossRefPubMed
Zurück zum Zitat Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G (2009) MiRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (epub ahead of print) Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G (2009) MiRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med (epub ahead of print)
Zurück zum Zitat Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, Ffrench M, Magaud JP (2009) Two new miR-16 targets: Caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell (epub ahead of print) Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, Ffrench M, Magaud JP (2009) Two new miR-16 targets: Caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell (epub ahead of print)
Zurück zum Zitat Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C, Li X, Sun F (2009) Altered miRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol 7:13CrossRefPubMed Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C, Li X, Sun F (2009) Altered miRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol 7:13CrossRefPubMed
Zurück zum Zitat Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M (2008) Genome-wide miRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216(4):418–427CrossRefPubMed Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M (2008) Genome-wide miRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216(4):418–427CrossRefPubMed
Zurück zum Zitat Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P (2009) MiRNAs and kidney cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 16(9):1047–1061CrossRefPubMed Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P (2009) MiRNAs and kidney cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 16(9):1047–1061CrossRefPubMed
Zurück zum Zitat Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008) Widespread deregulation of miRNA expression in human prostate cancer. Oncogene 27(12):1788–1793CrossRefPubMed Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008) Widespread deregulation of miRNA expression in human prostate cancer. Oncogene 27(12):1788–1793CrossRefPubMed
Zurück zum Zitat Tsang WP, Kwok TT (2009) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem (epub ahead of print) Tsang WP, Kwok TT (2009) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem (epub ahead of print)
Metadaten
Titel
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
verfasst von
Zhengjun Yi
Yurong Fu
Shushu Zhao
Xuguang Zhang
Chuanxiang Ma
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2010
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0726-x

Weitere Artikel der Ausgabe 6/2010

Journal of Cancer Research and Clinical Oncology 6/2010 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.